Last reviewed · How we verify

NCT05942248

The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis

Recruiting now NA Last updated 27 August 2024
What this trial tests

NA trial testing No Intervention in Acne in 150 participants. Currently enrolling.

Timeline
6 June 2023
Primary endpoint
31 January 2025
28 February 2025

Quick facts

Lead sponsorIntegrative Skin Science and Research
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationnon randomized
Designsingle group
Maskingnone
Primary purposeother
Enrollment150
Start date6 June 2023
Primary completion31 January 2025
Estimated completion28 February 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Integrative Skin Science and Research

Who can join

18 and older, any sex, with Acne or Melasma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is conducted to determine if image-based computer grading can of acne, melasma, rosacea and seborrheic dermatitis correlate well to expert based clinical severity grading.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No Intervention

Trials testing the same drug.

Other recruiting trials for Acne

Currently open trials in the same condition.

Other Integrative Skin Science and Research trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05942248.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing